Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kleedorfer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Comparative efficacy of two oral sustained-release preparations of L-dopa in fluctuating Parkinson's disease. Preliminary findings in 20 patientsB Kleedorfer, W Poewe
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1991
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effectsW Poewe, L Schelosky, B Kleedorfer
Der Nervenarzt|May 1, 1989
[Therapeutic experiences with a slow-release preparation of L-dopa (Madopar "HBS") in patients with advanced Parkinson disease]W Poewe, B Kleedorfer, F Gerstenbrand
Lancet (London, England)|December 23, 1989
Treatment of writers' dystoniaA J Lees, B Kleedorfer, H Foster
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's diseaseW Poewe, G Luef, B Kleedorfer, et al.
Lancet (London, England)|April 23, 1988
Subcutaneous apomorphine in Parkinson's diseaseW Poewe, B Kleedorfer, F Gerstenbrand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Subcutaneous and sublingual levodopa methyl ester in Parkinson's diseaseB Kleedorfer, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Buspirone in the treatment of levodopa induced dyskinesiasB Kleedorfer, A J Lees, G M Stern
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Primary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystoniaW H Poewe, B Kleedorfer, J Willeit, et al.
Advances in Neurology|January 1, 1993
Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patientsW Poewe, B Kleedorfer, M Wagner, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Comparative efficacy of two oral sustained-release preparations of L-dopa in fluctuating Parkinson's disease. Preliminary findings in 20 patientsB Kleedorfer, W Poewe
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1991
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effectsW Poewe, L Schelosky, B Kleedorfer
Der Nervenarzt|May 1, 1989
[Therapeutic experiences with a slow-release preparation of L-dopa (Madopar "HBS") in patients with advanced Parkinson disease]W Poewe, B Kleedorfer, F Gerstenbrand
Lancet (London, England)|December 23, 1989
Treatment of writers' dystoniaA J Lees, B Kleedorfer, H Foster
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's diseaseW Poewe, G Luef, B Kleedorfer, et al.
Lancet (London, England)|April 23, 1988
Subcutaneous apomorphine in Parkinson's diseaseW Poewe, B Kleedorfer, F Gerstenbrand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Subcutaneous and sublingual levodopa methyl ester in Parkinson's diseaseB Kleedorfer, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Buspirone in the treatment of levodopa induced dyskinesiasB Kleedorfer, A J Lees, G M Stern
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Primary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystoniaW H Poewe, B Kleedorfer, J Willeit, et al.
Advances in Neurology|January 1, 1993
Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patientsW Poewe, B Kleedorfer, M Wagner, et al.
Pageof 2